Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long Interspersed Nuclear Element-1 (LINE-1) Open Reading Frame 1 protein (ORF1p) is a 40 kDa RNA-binding protein and nucleic acid chaperone essential for the mobilization of LINE-1 retrotransposons (UniProt P12287). While LINE-1 elements are typically silenced in healthy adult somatic tissues through epigenetic mechanisms, they are frequently derepressed in a wide variety of cancers, including breast, lung, and colorectal carcinomas, where ORF1p expression serves as a highly specific biomarker (Taylor et al., 2023, Nature). ORF1p binds to LINE-1 mRNA to form a ribonucleoprotein (RNP) complex, facilitating its transport to the nucleus for reverse transcription and integration, a process that promotes genomic instability and triggers innate immune responses via the cGAS-STING pathway (De Cecco et al., 2019, Nature). Therapeutic strategies targeting ORF1p include small molecule inhibitors of its chaperone activity and immunotherapeutic approaches, such as vaccines or antibodies, aimed at selectively eliminating ORF1p-expressing malignant cells. Given its near-absence in normal tissues and high prevalence in tumors, ORF1p represents a promising pan-cancer target for both diagnostic and therapeutic applications.
Inhibition of LINE-1 retrotransposition and associated inflammatory signaling by blocking ORF1p chaperone activity or targeting ORF1p-expressing cells via immunotherapy.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long Interspersed Nuclear Element-1 Open Reading Frame 1 protein (ORF1p) (ORF1p).